DV
Dividend Vision

BMKDF — BioMark Diagnostics Inc

BioMark Diagnostics Inc (BMKDF)

Total return is 24.6% over the past 11.4 years, 321.0 points behind SPY at 345.6%. Its deepest 1-year drawdown was 28.4%.

BMKDF is an equity fund focused on BioMark Diagnostics Inc, a single-stock holding established in 2015. The fund provides direct exposure to a diagnostics company within the healthcare sector, though it does not currently distribute dividends as indicated by its N/A yield profile. This fund structure appeals primarily to investors seeking targeted exposure to a specific diagnostics company rather than those pursuing regular income distributions.

BMKDF key facts

Asset type
Stock
Asset class
Equity
Inception date
03/23/2015
Distribution frequency
None
Last close
$0.43
Market cap
$45,167,776
Average volume
38500.0
Beta
-0.311
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.01